News Conference News ACC 2024 KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives Shelley Wood April 11, 2024
News Conference News ACC 2024 Faster CAC Progression After Menopause May Warrant Intensified Therapy L.A. McKeown April 04, 2024
News Conference News ACC 2023 MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis Michael O'Riordan March 10, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Conference News ACC 2020 Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO Michael O'Riordan March 31, 2020
News Conference News ACC 2019 Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE Caitlin E. Cox March 25, 2019
News Conference News ACC 2018 Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure Shelley Wood March 12, 2018
News Conference News ACC 2017 People Living in Amazon Rainforest Provide Clues to Coronary Protection L.A. McKeown March 17, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016